Allan Grant Oberman, a director of Apotex Health Corp., sold 532,062 shares for $18.1 million on September 18, 2026, leaving him with no reported holdings, according to a SEDI filing.
What the filing shows
Allan Grant Oberman, a director of Apotex Health Corp. (TSX:APTX), sold 532,062 shares of the company at an average price of $34.00 per share, for a total value of $18.1 million, according to a filing on SEDI (System for Electronic Disclosure by Insiders).
The trade took place on September 18, 2026, and was filed the same day. Following the sale, Oberman held 0 shares, according to the filing. The filing described the transaction as leaving the insider with no reported holdings.
Allan Grant Oberman's trading at Apotex Health Corp.
Over the last 12 months, Oberman has reported one sale transaction at Apotex Health Corp., with a total value of $18.1 million, according to SEDI records.
That figure corresponds to the September 18, 2026 sale disclosed in this filing.
Other insider activity at Apotex Health Corp.
Other insiders also reported sales at Apotex Health Corp. in the past 30 days. LLC SK Artemis Holdings II, a 10% security holder of the issuer, sold shares with a total value of $654.6 million, with a latest trade date of September 18, 2026, according to SEDI. API Investment LP, also a 10% security holder of the issuer, sold shares with a total value of $177.3 million, with a latest trade date of September 18, 2026.
Over the last 12 months, three insiders at Apotex Health Corp. have reported sales, with a combined total value of $850.0 million, according to SEDI records. In the last 90 days, insiders at the company filed three trade reports of $100k or more, all of which were sales; no purchases of that size were reported in that period.
